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ABSTRACT 
The primary mission of the Cellular Biotechnology 
Program is to advance microgravity as a tool in basic and 
applied cell biology. The microgravity environment can 
be used to study fundamental principles of cell biology 
and to achieve specific applications such as tissue 
engineering. The Biotechnology Facility (BTF) will 
provide a state-of-the-art facility to perform cellular 
biotechnology research onboard the International Space 
Station (ISS). ' The BTF will support continuous 
operation, which will allow performance of long-duration 
experiments and will si@icantly increase the on-orbit 
science throughput. 
With the BTF, dedicated ground support, and a 
community of investigators, the goals of the Cellular 
Biotechnology Program at Johnson Space Center are to: 
Support approximately 400 typical investigator 
experiments during the nominal design life of BTF (10 
Support a steady increase in investigations per year, 
starting with stationary bioreactor experiments and 
adding rotating bioreactor experiments at a later date 
Support at least 80% of all new cellular biotechnology 
investigations selected through the NASA Research 
Announcement (NRA) process 
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Fig. 1. The proposed layout of the BiotechnoloG 
dual-rack component space. 
1. CAPABILITIES OF THE BTF 
The BTF will employ several methods to increase 
scientific return over the Cellular Biotechnology 
Operations Support System (CBOSS), which was an 
interim platform for cellular biotechnology research on 
ISS. 
0 Automated experiment operations - to reduce crew time 
requirements and to standardize experiment procedures 
0 Modular components - to allow sequential and 
continuous experiment operations without cross- 
contamination 
Increased cold storage capability (+4"C, -8O"C, 
0 Storage of fiozen cell culture inoculum - to allow 
0 Storage of post-experiment samples - for return of 
0 Increased number of cell cultures per investigation, 
with replicates - to provide sufficient number of 
samples for data analysis and publication of results in 
peer-reviewed scientific journals 
-180°C) 
sequential investigations 
high quality samples 
1.1 Core Functions 
The BTF will be a complete research laboratory facility 
that is equipped with the resources necessary to conduct 
cellular biotechnology experiments in the microgravity 
environment on the International Space Station. The BTF 
components provide four core functions: 
l . la  Cell Culture Incubation 
The BTF will provide a controlled environment for the 
cultivation of cells into three-dimensional tissues. These 
cell and tissue cultures, as well as the conditioned media, 
will be the primary source of sample material available to 
investigators for analysis. 
l . lb Experiment Support 
The BTF will provide the materials and hardware 
required to support cell and tissue culture experiments, 
including: 
0 Production of cell culture media 
Supply of tissue culture grade gas 
0 Cold storage 
0 +4"C: storage of culture media and other supplies, 
-80°C: storage of media supplements, post- 
0 - 180°C: storage of cell culture inoculum 
post-experiment samples 
experiment samples 
Ambient storage for experiment supplies 
l . lc  Experiment Assessment 
The BTF will provide capabilities to assess cell and tissue 
culture experiments. Capabilities include sensors in BTF 
components and use of a portable clinical blood gas 
analyzer. 
l . ld  Command and ControVData Handling 
The BTF will provide the command and control functions 
required to monitor and control the operation of BTF 
racks, to monitor the health and status of the BTF sub- 
rack components, and to partition resources to ensure that 
the maximum science return is achieved. The BTF will 
also provide experiment command and ControUdata 
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handling functions. These will include telemetry 
downlink and real-time command uplink from BTF 
Operations Support Facilities. 
2. COMPONENTS OF THE BTF 
2.1 Biotechnology Facility Components 
The BTF will consist of two Expedite the Processing of 
Experiments to the Space Station (EXPRESS) racks 
containing the sub-rack elements required to conduct 
cellular biotechnology research. Experiment hardware 
will feature a %igh through-put" cell and tissue culture 
system and several pieces of experiment-support 
hardware. The Automated Stationary Culture System 
(ASCS) is designed to accommodate multiple cultures 
and multiple investigations simultaneously. Additionally, 
the ASCS will allow end-to-end increment operation on 
ISS. Experiment support hardware will include: a water 
purification and media mixing system to produce cell 
culture media on-orbit (ACWA), a gas supply module 
(GSM), and dedicated cold storage facilities. 
2.la Automated Stationary Culture System (ASCS) 
The ASCS consists of two major components: the 
Thermal Carrier and Cell Culture Modules. The Thermal 
Camer provides +4"C storage for experiment supplies 
and preserved cultures. Cell Culture Modules (CCM) 
contain an insulated micro-incubator to provide 
appropriate environment for incubation of cell and tissue 
cultures. The ASCS contains four Cell Culture Modules 
per unit, and each CCM contains 3 cell culture vessels. 
Cell culture vessel volume is 10 ml per bag and samples 
may be either fixed cell cultures and/or media samples. 
The incubation temperature set point range is +25"C - 
45°C f 1°C. C02 set point range is 0 - 10% f 1%. 
Sample fixative storage temperature range: +4"C - 30°C f 
1°C. The ASCS has sensor capabilities for pH, CO,, and 
incubation and cold stowage temperatures. The ASCS has 
the following automated capabilities: media exchanges, 
low-shear mixing of culture vessel contents, pH 
monitoring, media sampling, culture wash and (seim- 
automated) fKation. Manual capabilities include a sample 
port on each cell culture vessel for sampling on an as- 
needed basis. 
2.lb Automated Culture Water Assembly (ACWA) 
The ACWA is designed to process water from any ISS 
potable water source into cell culture grade water. This is 
accomplished through an automated capability to obtain 
ultra-pure water, then mix the water with liquid media 
concentrate and pre-thawed media supplements to 
produce cell culture media. Additionally, the ACWA 
dispenses the produced media into the container(s) 
required by the BTF cell culture hardware. Wetted 
components are replaced to prevent cross-contamination 
from one media production to the next. The ACWA 
permits on-orbit filter change-out for extended duration 
operation. 
2.lc Gas Supply Module (GSM) 
The GSM provides tissue-culture grade gas for BTF cell 
culture hardware and experiments. The gas is pre-mixed 
on the ground, and will be between 0 and 10% CO, 
depending on the investigator's requirements. The GSM 
contains two gas output ports capable of simultaneous 
operation and has a flow rate delivery of a maximum of 
1000 standard cubic centimeters per minute (SCCM). 
Additionally, it provides quick disconnect regulated gas 
pressure of 40 f 7 psig and front panel displays for the 
storage pressure and the delivery pressure. 
2.ld Cold Stowage 
Currently, the BTF is planned to provided dedicated cold 
storage facilities for refigeration and cryogenic 
preservation of inoculum, media, and samples. These 
cold storage facilities are being developed by the ISS 
Payload Office. Capabilities include +4"C, -8O"C, and - 
180°C with both internal and external temperature 
sensing capabilities. 
2.le BTF Operations Support Facilities 
BTF real-time operations support will be coordinated 
from two dedicated workstations in the Telescience 
Support Center (TSC) at Johnson Space Center's Mission 
Control Center (MCC) and will provide ground to ground 
voice loops for communicating with the Payload 
Operations Integration Center (POIC) at Marshall Space 
Flight Center, ISS space to ground voice loops for 
monitoring crew communications, ISS payload downlink 
telemetry, ISS video downlmk, and ground commanding. 
Additionally, an alternate site for operations and 
experiment support will be established at Wyle 
Laboratories in Houston, TX and investigators will be 
able to monitor appropriate downlink data from a remote 
site through a password protected website. 
3. DEVELOPMENT STRATEGY 
3.1 
In the Preliminary Design phase, tests on the BTF have 
been performed at the system, subsystem, or component 
level to show that the specific design approaches are 
acceptable to meet the functional andor performance 
requirements of the hardware, firmware, and software. 
Development units (proof of concept models and test 
beds) composed of hardware and software that perform 
the basic functions of an engineering unit, have been 
constructed and results summarized below. 
Concepts Proven In Development Units 
3.la Concepts Validated in ASCS Model and Breadboards 
The ASCS proof-of-concept was successfully 
demonstrated in an incubation chamber housed in a +4"C 
volume that maintained the appropriate environment to 
support viable cell cultures (37"C, 5% CO,). Cell lines 
tested included both robust, fast growing cell lines, 
sensitive cell lines, and cell lines that utilize microcarrier 
beads. Using this proof-of-concept model, the 
automation of stationary cell culture operations was also 
validated; demonstrating successfully the rapid thaw of 
frozen inoculum, automated media exchanges, mixing of 
culture vessel contents, collection of media samples, cell 
r- 
culture wash and fixation, and short-term preservation of 
fixed cultures at +4"C. 
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Fig. 2. ASCS Proof of Concept Model 
3.lb ACWA Test Beds 
The ACWA proof-of-concept was successfully 
demonstrated in a water purification test bed, a media 
mixing test bed, and a complete ACWA test bed. In the 
water purification test bed, an ion exchange resin and 
activated carbon was used to remove biocides present in 
ISS water sources, and biological filters were used to 
remove endotoxins and bacteria. Test results showed 
biocompatibility of purified water, and was later 
confirmed by gene array analysis on cells cultured in 
media produced with ACWA-purified water. The media 
mixing test bed used lab supplied water mixed with 
concentrated media and supplements. Cells cultured in 
ACWA-mixed media were evaluated for growth, 
morphology and nutrient utilization and were similar to 
ground controls. Additionally, the media mixing test bed 
demonstrated the bubble removal capability. The 
complete ACWA test bed was used to pur@ water, mix 
with concentrated media and supplements, and showed 
that cells cultured in ACWA-prepared media were similar 
to controls for growth, morphology and nutrient 
utilizatinn 
Fig. 3. ACWA Media Mixing Test Bed 
4 CELLGROWEIINEARLYEN~GUNITS 
4.1 
Initial tests in the ACWA demonstrated that both MIP- 
101 and human lung fibroblasts (WI-38) showed similar 
cellular growth, morphology, and glucose utilization 
between cells cultured in ACWA media and in control 
media. The ACWA mixing test bed was utilized to 
prepare GTSF-2 media by mixing cell culture grade water 
with 3X liquid media concentrate and media supplements. 
Human colorectal carcinoma cells (MI€'-101) were 
cultured in the ACWA prepared media and in lab- 
prepared control media for six days. 
Cells Cultured in Media Prepared with ACWA 
4.2 
Initial tests in the ASCS Proof of Concept Model 
demonstrated that an insulated incubation chamber 
housed at +4"C will support viable cell cultures. 
Cells Cultured in ASCS Model 
MIP-101 human colorectal carcinoma cells were 
successllly cultured in the ASCS for seven days. 
Cellular growth, morphology and nutrient utilization were 
similar to control cultures housed in a standard laboratory 
incubator. Within 24 hours of inoculation, MIP-101 cells 
formed three-dimensional aggregates. As the cells 
proliferated, the aggregates increased in size and number. 
Following the test, aggregates were exposed to MTT 
reagent to confirm cell viability. Metabolically active 
cells appeared purple. In additional tests, EMS-3 
Rauscher murine erythroleukemia cells were successfllly 
cultured in the ASCS model. 
4.3 
Subsequent tests in the ASCS Proof of Concept Model 
demonstrated that the key concepts required to perform a 
complete cell culture experiment in the ASCS can be 
successfully achieved. 
Cells on Microcarrier Beads in ASCS Model 
0 Rapid thaw of fiozen inoculum 
0 Dilution and removal of cryopreservation agent 
0 Culture incubation (37OC, 5% CO,) 
0 Automated media exchanges 
0 Automated collection of media samples 
0 Automated wash and fixation of cell cultures 
0 Short-term storage of fvred cultures at +4"C 
MIP-101 human colorectal carcinoma cells were cultured 
with microcarrier beads in the ASCS for seven days. 
Cellular growth, morphology and nutrient utilization were 
similar to control cultures housed in a standard laboratory 
incubator. Cells were washed with PBS and fvred with 
formalin. Following the test, fixed cells were stained 
with hematoxylin to confirm preservation of cell 
morphology. 
5. ENGINEERING DATA 
5.1 Computational Fluid Dynamics Analysis 
A mixing procedure is necessary for the stationary culture 
vessels to distribute inoculum, fresh media, or other 
treatments uniformly throughout the cell culture vessel 
volume. Mixing will also provide an even distribution of 
nutrients throughout the cell culture vessel, which is 
essential to promote cell growth and aggregate formation. 
A kneading-like mixing protocol that transfers the cell 
culture media from one side of the culture vessel to the 
other has been proposed for use in the Automated 
Stationary Culture System (ASCS). This protocol has 
been modeled using FLUENT, a computational fluid 
dynamics tool. The mixing process will produce low 
mechanical stress levels and a laminar flow to avoid 
damage to the shear sensitive cells. The mixing protocol 
will use a low frequency of oscillation (0.1 Hz) and a 1.5 
ml volume displacement to produce a 0.0024 dynes/cm' 
maximum shear stress, which is 60-fold less than the 
critical 0.15 dynes/c& level which harms cells. 
Preliminary CFD analysis has demonstrated that this 
protocol will result in effective mixing within minutes. 
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Fig. 4. After 3 Cycles, Time= 10 seconds 
These images show the results of a fluid dynamics 
analysis conducted using FLUENT" software to simulate 
the proposed method of mixing within the culture 
vessels. The simulation tracks mixing of relative oxygen 
concentration from 100% to 14% over three cycles. This 
prelirmnary data is based on saturated oxygen fluid 
modeling. Additional analysis is required to evaluate 
cells, cell aggregates, and media agent mixing. 
6. FIELDS OF INVESTIGATION 
6.1 Major Investigation Areas 
It is anticipated that the BTF will be utilized by ISS 
investigators in the followine areas of study: 
3-D Tumor Modeling Membrane Dynamics 
Angiogenesis Microencapsulation 
Apoptosis Models for Disease 
Biomateials Molecular Biology 
Biosensors Pharmaceutical Studies 
Biosentinels Proteomics 
Cellular Countermeasures Radiation Modeling 
Cellular Locomotion Signal Transduction 
Cellular Metabolism 
Cellular Physiology 
Differentiation 
Genomics 
Tissue Engineering 
Tissue Morphogenesis 
Tissue Transplantation 
Toxicology 
Some typical goals for expected microgravity investigations 
would be: 
0 Compare activation and/or deactivation of genes 
0 Examine alterations in cell motility 
0 Examine changes in cellular structure 
0 Examine changes to signal transduction pathways 
0 Examine alterations to enzyme-mediated chemical 
0 Observe apoptotic changes 
0 Construct complex functional tissues 
0 Compare types and quantity of protein production 
activity 
6.2 Application of Findings 
Microgravity can be used as a powerful research tool. 
Cellular responses to the stress of exposure to 
microgravity can provide insight into basic cellular 
mechanisms. The microgravity environment can also be 
used to facatate construction of functional tissues that 
either can not be assembled in 1G or that are difficult to 
grow on Earth. Knowledge gained from cellular 
biotechnology microgravity experiments can be applied 
to disease fighting efforts on Earth and aid in the genesis 
of potential cellular countermeasures for human space 
flight. 
7. CONTACT INFORMATION: 
For additional information on NASA's Biotechnology 
Facility for ISS, please contact the BTF Project Manager 
Katy Hurlbert, PbD , katv.hurlbert@,isc.nasa.gov or the 
BTF Project Scientist, Thomas Good- Ph.D. , 
thomas.goodwin@,isc.nasa.gov. Also, you can find 
information at the Biological Systems Office Website at: 
http://slsd.j sc.nasa.gov/bso 
